Megan Doyle, PhD, currently serves as SVP and Medical Group Leader at MERGE, overseeing scientific and medical strategy for various accounts since February 2020. Previously held positions include Senior Director of Scientific Strategy at Envision Communications and Scientific Director at Razorfish Health. Megan Doyle has extensive experience in medical science strategy, focusing on relationship development, KOL recruitment, and content creation across multiple therapeutic areas, including oncology and cardiovascular medicine. Earlier roles include Associate Scientific Director at Discovery USA and Scientific Content Specialist at Cadent Medical Communications. Megan Doyle earned a PhD in Biomedical Engineering from the University of Virginia and a BS in Chemical Engineering from The University of Texas at Austin.
This person is not in any teams
This person is not in any offices
MERGE
3 followers
MERGE promotes health, wealth and happiness in the world by merging storytelling with technology and offers marketing and technology clients full-service capabilities including strategy, creative communications, experience engineering, performance marketing, media and marketing operations platforms. MERGE has enduring client partnerships with American Express, T-Mobile, LG, Kate Spade NY, Coach, The North Face, Meta, BlueCross BlueShield, Abbott, Supernus, Seqirus, GE Healthcare, Indiana University Health, Nationwide and Fidelity. With 750+ employees across offices in Atlanta, Boston, Chicago, Denver, Kansas City, Montreal, New York City and Los Angeles, MERGE uses a talent-to-task process that enables clients to think higher and feel deeper about their customers.